TY - JOUR
T1 - Factors associated with the development of coronary artery disease in people with HIV
AU - Mushin, Ari S.
AU - Trevillyan, Janine M.
AU - Lee, Sue J.
AU - Hearps, Anna C.
AU - Hoy, Jennifer F.
N1 - Publisher Copyright:
© 2023 The Author(s) (or their employer(s)). Published by CSIRO Publishing.
PY - 2023
Y1 - 2023
N2 - Background: People living with HIV (PLHIV) are at increased risk for coronary artery disease (CAD). This study aimed to describe the features associated with CAD in PLHIV. Methods: A case ([n = 160] PLHIV with CAD) control ([n = 317] PLHIV matched by age and sex without CAD) study was performed at the Alfred Hospital, Melbourne, Australia (January 1996 and December 2018). Data collected included CAD risk factors, duration of HIV infection, nadir and at-event CD4+ T-cell counts, CD4:CD8 ratio, HIV viral load, and antiretroviral therapy exposure. Results: Participants were predominantly male (n = 465 [97.4%]), with a mean age of 53 years. Traditional risk factors associated with CAD in univariate analysis included hypertension (OR 11.4 [95%CI 5.01, 26.33], P < 0.001), current cigarette smoking (OR 2.5 [95% CI 1.22, 5.09], P = 0.012), and lower high-density lipoprotein cholesterol (OR 0.14 [95%CI 0.05, 0.37], P < 0.001). There was no association between duration of HIV infection, nadir or current CD4 cell count. However, current and ever exposure to abacavir (cases: 55 [34.4%]; controls: 79 [24.9%], P = 0.023 and cases: 92 [57.5%]; controls: 154 [48.6%], P = 0.048, respectively) was associated with CAD. In conditional logistic regression analysis, current abacavir use, current smoking, and hypertension remained significantly associated (aOR = 1.87 [CI = 1.14, 3.07], aOR = 2.31 [1.32, 4.04], and aOR = 10.30 [5.25, 20.20] respectively). Conclusion: Traditional cardiovascular risk factors and exposure to abacavir were associated with CAD in PLHIV. This study highlights that aggressive management of cardiovascular risk factors remains critical for reducing risk in PLHIV.
AB - Background: People living with HIV (PLHIV) are at increased risk for coronary artery disease (CAD). This study aimed to describe the features associated with CAD in PLHIV. Methods: A case ([n = 160] PLHIV with CAD) control ([n = 317] PLHIV matched by age and sex without CAD) study was performed at the Alfred Hospital, Melbourne, Australia (January 1996 and December 2018). Data collected included CAD risk factors, duration of HIV infection, nadir and at-event CD4+ T-cell counts, CD4:CD8 ratio, HIV viral load, and antiretroviral therapy exposure. Results: Participants were predominantly male (n = 465 [97.4%]), with a mean age of 53 years. Traditional risk factors associated with CAD in univariate analysis included hypertension (OR 11.4 [95%CI 5.01, 26.33], P < 0.001), current cigarette smoking (OR 2.5 [95% CI 1.22, 5.09], P = 0.012), and lower high-density lipoprotein cholesterol (OR 0.14 [95%CI 0.05, 0.37], P < 0.001). There was no association between duration of HIV infection, nadir or current CD4 cell count. However, current and ever exposure to abacavir (cases: 55 [34.4%]; controls: 79 [24.9%], P = 0.023 and cases: 92 [57.5%]; controls: 154 [48.6%], P = 0.048, respectively) was associated with CAD. In conditional logistic regression analysis, current abacavir use, current smoking, and hypertension remained significantly associated (aOR = 1.87 [CI = 1.14, 3.07], aOR = 2.31 [1.32, 4.04], and aOR = 10.30 [5.25, 20.20] respectively). Conclusion: Traditional cardiovascular risk factors and exposure to abacavir were associated with CAD in PLHIV. This study highlights that aggressive management of cardiovascular risk factors remains critical for reducing risk in PLHIV.
KW - antiretroviral therapy
KW - atherosclerosis
KW - cardiac risk
KW - cardiovascular disease
KW - Framingham Risk Score
KW - HIV
KW - hypertension
KW - smoking
UR - http://www.scopus.com/inward/record.url?scp=85165599931&partnerID=8YFLogxK
U2 - 10.1071/SH23043
DO - 10.1071/SH23043
M3 - Article
C2 - 37394729
AN - SCOPUS:85165599931
SN - 1448-5028
VL - 20
SP - 470
EP - 474
JO - Sexual Health
JF - Sexual Health
IS - 5
ER -